Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity is now under attack on multiple fronts, from ...

British industry leaders fear tariffs imposed by President Trump could disrupt the supply and even the price of drugs ...

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...

Novo Nordisk and Dicerna selected the first development candidate from the collaboration earlier this year, a drug for cardiometabolic diseases which is due to start clinical testing in 2022.